Currently, antioxidant compounds, such as vitamins C and E, are widely used to deactivate free oxygen radical species (ROS), playing an essential role in preventing chronic neurodegenerative diseases where ROS levels are significantly increased 1,2. Herein, single-walled carbon nanocones (SWCNC), a nanocarbon allotrope with unique physico-chemical properties, was combined with antioxidant vitamins C and E toward exploring mitochondrial nanomedicine applications in molecular neurosciences 3,4.To this end, we carried out the study of SWCNCs interaction with vitamin C and vitamin E using ab initio calculations based on Density Functional Theory5.Besides, molecular docking methodology was applied by selecting the human ABC-mitochondrial carrier ABCB10, PDB ID: 4ayt to address the study of molecular interactions with the antioxidant vitamins C and E 6. The results obtained from ab initio study, showed that the most stable configuration was observed for the SWCNC interacting with vitamin C >> vitamin E, with DFT-binding energy of 0.98 and 0.56 eV, respectively. The results on molecular docking study provided a free binding energy (FEB) and rmsd for the neurotarget (4ayt) following the order of as: ABC-carrier/SWCNCs (-17.6 Kcal / mol and 0.931 Å)>>ABC-carrier/vitamin E (-5.4 Kcal / mol and 0.911 Å) and ABC-carrier/vitamin C (-4.5 Kcal / mol and 1.567 Å), and SWCNCs simultaneously interacting with vitamin E on ABC-carrier was -18 Kcal /mol and r.m.s.d = 0.079 Å). Lastly, the results suggest that the potential therapeutic combination of SWCNTs with vitamins E > C, could be a new and promising alternative for neurotherapy-based nanomedicine.
References